This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Ika I. Peleg, MD; Hilda T. Maibach, MS; Steven H. Brown, MD; C. Mel Wilcox, MD

Arch Intern Med. 1994;154(4):394-400.

Abstract
Objective
To test the hypothesis that the regular use of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) is negatively associated with the risk of subsequent colorectal cancer.

Design
Case-control study with four age- and sex-matched control subjects for each incident colorectal cancer case. Population and Setting: Patient population of a large municipal teaching hospital in Atlanta, Ga.

Main Outcome Measure
Odds of colorectal cancer as a function of aspirin, nonaspirin NSAIDs, and acetaminophen dispensed to the study population in the 4 years prior to incident colorectal cancer diagnosis.

Main Results
The risk of colorectal cancer estimated by odds ratios decreased with inceasing days of exposure to aspirin linearly in a dose-dependent fashion (likelihood ratio statistic: for cumulative days, P<.001; for cumulative dose, P<.0001). The coefficient for days of exposure to aspirin was highly significant even when modeled as a continuous variable (P=.001). There appeared to be a threshold above which nonaspirin NSAIDs afforded protection (likelihood ratio statistic: for cumulative days, P=.021; for cumulative dose, P=.019). Acetaminophen conferred no risk reduction.

Conclusion
The results of previous experimental animal models, interventional case studies, and some but not all epidemiological investigations and the present data point toward a causal relationship between NSAID use and the prevention of cancer of the large bowel and rectum. Because of the potential gastrointestinal and renal side effects of NSAID use, particularly in the elderly, chemoprevention trials are now needed to allow riskbenefit analysis in populations at high risk for colorectal cancer.

(Arch Intern Med. 1994;154:394-399)

Author Affiliations
From the Medical Service, Grady Memorial Hospital (Drs Peleg, Brown, and Wilcox), and the Division of Biostatistics, Emory University School of Public Health (Ms Maibach), Emory University School of Medicine, Atlanta, Ga.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Use of Nonsteroidal Antiinflammatory Drugs and Distal Large Bowel Cancer in Whites and African Americans
Kim et al.
Am J Epidemiol 2008;168:1292-1300.
ABSTRACT | FULL TEXT  

The Effect of Meloxicam, a Selective COX-2 Inhibitor, on the Microvasculature of Small Metastatic Liver Tumors in Rats
Iwase et al.
Jpn J Clin Oncol 2007;37:673-678.
ABSTRACT | FULL TEXT  

Azoxymethane protects intestinal stem cells and reduces crypt epithelial mitosis through a COX-1-dependent mechanism
Riehl et al.
Am. J. Physiol. Gastrointest. Liver Physiol. 2006;291:G1062-G1070.
ABSTRACT | FULL TEXT  

Nonsteroidal Anti-inflammatory Drugs and Subsite-Specific Colorectal Cancer Incidence in the Iowa Women's Health Study.
Mahipal et al.
Cancer Epidemiol. Biomarkers Prev. 2006;15:1785-1790.
ABSTRACT | FULL TEXT  

The Association between Aspirin Use and the Incidence of Colorectal Cancer in Women
Allison et al.
Am J Epidemiol 2006;164:567-575.
ABSTRACT | FULL TEXT  

Use of Nonsteroidal Antiinflammatory Drugs and Risk of Colon Cancer in a Population-based, Case-Control Study of African Americans and Whites
Sansbury et al.
Am J Epidemiol 2005;162:548-558.
ABSTRACT | FULL TEXT  

Long-term Use of Aspirin and Nonsteroidal Anti-inflammatory Drugs and Risk of Colorectal Cancer
Chan et al.
JAMA 2005;294:914-923.
ABSTRACT | FULL TEXT  

Statins and the Risk of Colorectal Cancer
Poynter et al.
NEJM 2005;352:2184-2192.
ABSTRACT | FULL TEXT  

Nonsteroidal Anti-inflammatory Drugs and Risk of Esophageal and Gastric Cancer
Lindblad et al.
Cancer Epidemiol. Biomarkers Prev. 2005;14:444-450.
ABSTRACT | FULL TEXT  

Concomitant Overexpression of Cyclooxygenase-2 in HER-2-Positive on Smad4-Reduced Human Gastric Carcinomas Is Associated with a Poor Patient Outcome
Okano et al.
Clin. Cancer Res. 2004;10:6938-6945.
ABSTRACT | FULL TEXT  

Prostaglandin E2 Synergistically Enhances Receptor Tyrosine Kinase-dependent Signaling System in Colon Cancer Cells
Shao et al.
J. Biol. Chem. 2004;279:14287-14293.
ABSTRACT | FULL TEXT  

Use of NSAIDs for the Chemoprevention of Colorectal Cancer
Herendeen and Lindley
The Annals of Pharmacotherapy 2003;37:1664-1674.
ABSTRACT | FULL TEXT  

A Randomized Trial of Aspirin to Prevent Colorectal Adenomas in Patients with Previous Colorectal Cancer
Sandler et al.
NEJM 2003;348:883-890.
ABSTRACT | FULL TEXT  

Epidemiology of colorectal cancer
Boyle and Leon
Br Med Bull 2002;64:1-25.
ABSTRACT | FULL TEXT  

Inhibitory Effects of Sodium Salicylate and Acetylsalicylic Acid on UVB-induced Mouse Skin Carcinogenesis
Bair et al.
Cancer Epidemiol. Biomarkers Prev. 2002;11:1645-1652.
ABSTRACT | FULL TEXT  

Nonsteroidal Anti-inflammatory Drug Use, Body Mass Index, and Anthropometry in Relation to Genetic and Flow Cytometric Abnormalities in Barrett's Esophagus
Vaughan et al.
Cancer Epidemiol. Biomarkers Prev. 2002;11:745-752.
ABSTRACT | FULL TEXT  

Nonsteroidal Anti-inflammatory Drugs as Anticancer Agents: Mechanistic, Pharmacologic, and Clinical Issues
Thun et al.
JNCI J Natl Cancer Inst 2002;94:252-266.
ABSTRACT | FULL TEXT  

Aspirin as an Adjunct to Screening for Prevention of Sporadic Colorectal Cancer: A Cost-Effectiveness Analysis
Ladabaum et al.
ANN INTERN MED 2001;135:769-781.
ABSTRACT | FULL TEXT  

Suppression of Tumor Cell Growth Both in Nude Mice and in Culture by n-3 Polyunsaturated Fatty Acids: Mediation through Cyclooxygenase-independent Pathways
Boudreau et al.
Cancer Res. 2001;61:1386-1391.
ABSTRACT | FULL TEXT  

Effects of Piroxicam on Prostaglandin E2 Levels in Rectal Mucosa of Adenomatous Polyp Patients: A Randomized Phase IIb Trial
Calaluce et al.
Cancer Epidemiol. Biomarkers Prev. 2000;9:1287-1292.
ABSTRACT | FULL TEXT  

Sulindac Sulfone Inhibits K-ras-dependent Cyclooxygenase-2 Expression in Human Colon Cancer Cells
Taylor et al.
Cancer Res. 2000;60:6607-6610.
ABSTRACT | FULL TEXT  

Chemoprevention of Colorectal Cancer
Janne and Mayer
NEJM 2000;342:1960-1968.
FULL TEXT  

Effect of Subacute Ibuprofen Dosing on Rectal Mucosal Prostaglandin E2 Levels in Healthy Subjects with a History of Resected Polyps
Chow et al.
Cancer Epidemiol. Biomarkers Prev. 2000;9:351-356.
ABSTRACT | FULL TEXT  

Genetically Tailored Preventive Strategies: an Effective Plan for the Twenty-first Century?
Li and Whittemore
Cancer Epidemiol. Biomarkers Prev. 1999;8:649-658.
ABSTRACT | FULL TEXT  

Empirical Derivation of an Electronic Clinically Useful Problem Statement System
Brown et al.
ANN INTERN MED 1999;131:117-126.
ABSTRACT | FULL TEXT  

Colorectal Cancer: Molecules and Populations
Potter
JNCI J Natl Cancer Inst 1999;91:916-932.
ABSTRACT | FULL TEXT  

Coordinate regulation of cyclooxygenase-2 and TGF-ß1 in replication error-positive colon cancer and azoxymethane-induced rat colonic tumors
Shao et al.
Carcinogenesis 1999;20:185-191.
ABSTRACT | FULL TEXT  

Use of Nonsteroidal Anti-inflammatory Drugs and Incidence of Colorectal Cancer: A Population-Based Study
Smalley et al.
Arch Intern Med 1999;159:161-166.
ABSTRACT | FULL TEXT  

Chemoprevention of colorectal cancer
LANGMAN and BOYLE
Gut 1998;43:578-585.
ABSTRACT | FULL TEXT  

Inhibition of Ultraviolet B-induced Activator Protein-1 (AP-1) Activity by Aspirin in AP-1-Luciferase Transgenic Mice
Huang et al.
J. Biol. Chem. 1997;272:26325-26331.
ABSTRACT | FULL TEXT  

Altered Sensitivity of Aspirin-Acetylated Prostaglandin G/H Synthase-2 to Inhibition by Nonsteroidal Anti-Inflammatory Drugs
Mancini et al.
Mol. Pharmacol. 1997;51:52-60.
ABSTRACT | FULL TEXT  

Aspirin and the Risk of Colorectal Cancer in Women
Giovannucci et al.
NEJM 1995;333:609-614.
ABSTRACT | FULL TEXT  

Aspirin and the Risk of Digestive Cancers-Reply
Peleg and Wilcox
Arch Intern Med 1995;155:214-217.
ABSTRACT  

Aspirin and the Risk of Digestive Cancers
Morgan
Arch Intern Med 1995;155:213-214.
ABSTRACT  

Regulation of Constitutive Cyclooxygenase-2 Expression in Colon Carcinoma Cells
Shao et al.
J. Biol. Chem. 2000;275:33951-33956.
ABSTRACT | FULL TEXT  

Prostaglandin E2 Increases Growth and Motility of Colorectal Carcinoma Cells
Sheng et al.
J. Biol. Chem. 2001;276:18075-18081.
ABSTRACT | FULL TEXT